Profile
Leodevico L.
Ilag was the founder of Xerion Pharmaceuticals AG, serving as MD, Chief Scientific & Technology Officer from 1998 to 2004.
Dr. Ilag is currently a Non-Executive Director at Plentex Ltd. since 2021.
Former positions include Chief Operating Officer at Patrys Ltd. and Chief Scientific Officer at Manalto Ltd.
Leodevico L. Ilag active positions
| Companies | Position | Start |
|---|---|---|
| PLENTEX LIMITED | Director/Board Member | 22/07/2021 |
Former positions of Leodevico L. Ilag
| Companies | Position | End |
|---|---|---|
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Founder | 01/01/2004 |
| MANALTO LIMITED | Chief Tech/Sci/R&D Officer | - |
| PATRYS LIMITED | Chief Operating Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Patrys Ltd.
Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Plentex Ltd.
Plentex Ltd. Agricultural Commodities/MillingProcess Industries Produces, develops and supplies algae oil to the biological and fuel industry | Process Industries |
Manalto Ltd.
Manalto Ltd. Packaged SoftwareTechnology Services Develops and commercializes social media management software | Technology Services |
Xerion Pharmaceuticals AG
Xerion Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops antibodies and therapeutic targets | Health Technology |
- Stock Market
- Insiders
- Leodevico L. Ilag
















